The challenges of managing NTM disease

DAY 2

Chaired by: Rhys Hurst (Cambridge) and Christabelle Chen (London)

2.00pm - Managing complex NTM – who, when and how to treat: clinical cases and management dilemmas
Devesh Dhasmana (Fife)

2.30pm - Multidisciplinary management of NTM: how can we deliver this in practice
Jennie Keane (Rochford)

3.00pm - What matters most to people affected by NTM?
Shirley Harwood, NTM Patient Care UK 
Sarah Minty, NTM Patient Care UK 
Sandra Christian, NTM Patient Care UK 

2:00 PM

90 MINUTE SESSION

Learning outcomes

  • To understand the complexity of clinical management of NTM disease, problems that can be encountered and options for management.
  • To gain knowledge of the multi-disciplinary approach to the clinical management of NTM infection, what this looks like in the NHS and how it can be achieved.
  • To understand what is important to patients and what outcomes are most meaningful to them 

Curriculum mapping

  • Non-tuberculous mycobacterial infection is an important and expanding clinical subject and one that all respiratory trainees will need to have some knowledge.
  • The course delivers training that overlaps with CiPs 2, 3 and 6 of the Respiratory Curriculum:
    • 2. Managing integrated respiratory medicine across the primary and secondary care interface including management of long-term disease
      • Works in partnership with the Respiratory Multi-disciplinary team (e.g. physiotherapists, specialist nurses, palliative care team, pharmacists, physiologists, and psychologists) 
    • 3. Managing complex and unusual respiratory infection including contact tracing and public health (in particular atypical pneumonia)
      • Demonstrates accurate diagnosis of patients presenting with pulmonary infections including interpretation of clinical features, investigations, and laboratory results.
      • Demonstrates knowledge and interpersonal skills in dealing with immunocompromised patients.
      • Demonstrates appropriate management of patients diagnosed with pulmonary infections including appropriate selection of drugs.
    • 6. Managing the use of drugs and therapeutic modalities specific to the practice of respiratory medicine